Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017, Article ID 6719345, 6 pages
https://doi.org/10.1155/2017/6719345
Research Article

Factors Predicting the Adherence to the Therapy of Italian IBD Patients

Department of Medicine and Surgery, Scuola Medica Salernitana, AOU San Giovanni di Dio and Ruggi d’Aragona, IBD Center at the University of Salerno, Salerno, Italy

Correspondence should be addressed to Carolina Ciacci; ti.asinu@iccaicc

Received 27 March 2017; Revised 20 June 2017; Accepted 6 July 2017; Published 7 August 2017

Academic Editor: Paolo Gionchetti

Copyright © 2017 Cristina Bucci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. G. Kaplan, “The global burden of IBD: from 2015 to 2025,” Nature Reviews Gastroenterology & Hepatology, vol. 12, no. 12, pp. 720–727, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. A. M. McCombie, R. T. Mulder, and R. B. Gearry, “How IBD patients cope with IBD: a systematic review,” Journal of Crohn's & Colitis, vol. 7, no. 2, pp. 89–106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. P. V. Burkhart and E. Sabate, “Adherence to long-term therapies: evidence for action,” Journal of Nursing Scholarship, vol. 35, no. 3, p. 207, 2003. View at Google Scholar
  4. J. Dunbar-Jacob, J. A. Erlen, E. A. Schlenk, C. M. Ryan, S. M. Sereika, and W. M. Doswell, “Adherence in chronic disease,” Annual Review of Nursing Research, vol. 18, pp. 48–90, 2000. View at Google Scholar
  5. P. Bager, M. Julsgaard, T. Vestergaard, L. A. Christensen, and J. F. Dahlerup, “Adherence and quality of care in IBD,” Scandinavian Journal of Gastroenterology, vol. 51, no. 11, pp. 1326–1331, 2016. View at Google Scholar
  6. C. H. Tae, S. A. Jung, H. S. Moon et al., “Importance of patients’ knowledge of their prescribed medication in improving treatment adherence in inflammatory bowel disease,” Journal of Clinical Gastroenterology, vol. 50, no. 2, pp. 157–162, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. P. D. Higgins, D. T. Rubin, K. Kaulback, P. S. Schoenfield, and S. V. Kane, “Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares,” Alimentary Pharmacology & Therapeutics, vol. 29, no. 3, pp. 247–257, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. V. Kane, J. Chao, and P. M. Mulani, “Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn’s disease patients,” Advances in Therapy, vol. 26, no. 10, pp. 936–946, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Elkjaer, “E-health: web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance,” Danish Medical Journal, vol. 59, no. 7, p. B4478, 2012. View at Google Scholar
  10. N. Pedersen, “EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS,” Danish Medical Journal, vol. 62, no. 12, p. B5168, 2015. View at Google Scholar
  11. M. de Jong, A. van der Meulen-de Jong, M. Romberg-Camps et al., “Development and feasibility study of a telemedicine tool for all patients with IBD: MyIBDcoach,” Inflammatory Bowel Diseases, vol. 23, no. 4, pp. 485–493, 2017. View at Publisher · View at Google Scholar
  12. K. C. Farmer, “Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice,” Clinical Therapeutics, vol. 21, no. 6, pp. 1073–1090, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. D. E. Morisky, A. Ang, M. Krousel‐Wood, and H. J. Ward, “Predictive validity of a medication adherence measure in an outpatient setting,” Journal of Clinical Hypertension (Greenwich, Conn.), vol. 10, no. 5, pp. 348–354, 2008. View at Google Scholar
  14. S. Kane, B. Becker, W. S. Harmsen, A. Kurian, D. E. Morisky, and A. R. Zinsmeister, “Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease,” The American Journal of Gastroenterology, vol. 107, no. 2, pp. 154–160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. R. Goodhand, N. Kamperidis, B. Sirwan et al., “Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease,” Alimentary Pharmacology & Therapeutics, vol. 38, no. 9, pp. 1097–1108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Krousel-Wood, T. Islam, L. S. Webber, R. Re, D. E. Morisky, and P. Muntner, “New medication adherence scale versus pharmacy fill rates in seniors with hypertension,” The American Journal of Managed Care, vol. 15, no. 1, pp. 59–66, 2009. View at Google Scholar
  17. D. E. Morisky and M. R. DiMatteo, “Improving the measurement of self-reported medication nonadherence: response to authors,” Journal of Clinical Epidemiology, vol. 64, no. 3, pp. 255–263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. J. Trindade, A. Ehrlich, A. Kornbluth, and T. A. Ullman, “Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence,” Inflammatory Bowel Diseases, vol. 17, no. 2, pp. 599–604, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. R. D’Incà, P. Bertomoro, K. Mazzocco, M. G. Vettorato, R. Rumiati, and G. C. Sturniolo, “Risk factors for non-adherence to medication in inflammatory bowel disease patients,” Alimentary Pharmacology & Therapeutics, vol. 27, no. 2, pp. 166–172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Zelante, A. De Giorgi, R. Borgoni, L. Trevisani, and M. Gallerani, “Adherence to medical treatment in inflammatory bowel disease patients,” Minerva Gastroenterologica e Dietologica, vol. 60, no. 4, pp. 269–274, 2014. View at Google Scholar
  21. D. R. van Langenberg and J. M. Andrews, “Satisfaction with patient-doctor relationships in inflammatory bowel diseases: examining patient-initiated change of specialist,” World Journal of Gastroenterology, vol. 18, no. 18, pp. 2212–2218, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. D. T. Rubin and N. Krugliak Cleveland, “Using a treat-to-target management strategy to improve the doctor-patient relationship in inflammatory bowel disease,” The American Journal of Gastroenterology, vol. 110, no. 9, pp. 1252–1256, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Mountifield, J. M. Andrews, A. Mikocka-Walus, and P. Bampton, “Doctor communication quality and friends’ attitudes influence complementary medicine use in inflammatory bowel disease,” World Journal of Gastroenterology, vol. 21, no. 12, pp. 3663–3670, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. P. L. Lakatos, “Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it?” World Journal of Gastroenterology, vol. 15, no. 34, pp. 4234–4239, 2009. View at Google Scholar
  25. S. V. Kane, R. D. Cohen, J. E. Aikens, and S. B. Hanauer, “Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis,” The American Journal of Gastroenterology, vol. 96, no. 10, pp. 2929–2933, 2001. View at Publisher · View at Google Scholar
  26. P. Cerveny, M. Bortlík, A. Kuběna, J. Vlček, P. L. Lakatos, and M. Lukáš, “Nonadherence in inflammatory bowel disease: results of factor analysis,” Inflammatory Bowel Diseases, vol. 13, no. 10, pp. 1244–1249, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. J. Sewitch, M. Abrahamowicz, A. Barkun et al., “Patient nonadherence to medication in inflammatory bowel disease,” The American Journal of Gastroenterology, vol. 98, no. 7, pp. 1535–1544, 2003. View at Publisher · View at Google Scholar
  28. G. Rubin, A. P. Hungin, D. Chinn, A. D. Dwarakanath, L. Green, and J. Bates, “Long-term aminosalicylate therapy is under-used in patients with ulcerative colitis: a cross-sectional survey,” Alimentary Pharmacology & Therapeutics, vol. 16, no. 11, pp. 1889–1893, 2002. View at Google Scholar
  29. I. Bernal, E. Domènech, E. Garcia-Planella et al., “Medication-taking behavior in a cohort of patients with inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 51, no. 12, pp. 2165–2169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Lopez, V. Billioud, C. Peyrin-Biroulet, and L. Peyrin-Biroulet, “Adherence to anti-TNF therapy in inflammatory bowel diseases: a systematic review,” Inflammatory Bowel Diseases, vol. 19, no. 7, pp. 1528–1533, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. P. H. Beardon, M. M. McGilchrist, A. D. McKendrick, D. G. McDevitt, and T. M. MacDonald, “Primary non-compliance with prescribed medication in primary care,” BMJ, vol. 307, no. 6908, pp. 846–848, 1993. View at Google Scholar
  32. M. D. Kappelman, S. L. Rifas–Shiman, C. Q. Porter et al., “Direct health care costs of Crohn’s disease and ulcerative colitis in US children and adults,” Gastroenterology, vol. 135, no. 6, pp. 1907–1913, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Burisch, T. Jess, M. Martinato, P. L. Lakatos, and ECCO-EpiCom, “The burden of inflammatory bowel disease in Europe,” Journal of Crohn's & Colitis, vol. 7, no. 4, pp. 322–337, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Bortoli, M. Daperno, A. Kohn et al., “Patient and physician views on the quality of care in inflammatory bowel disease: results from SOLUTION-1, a prospective IG-IBD study,” Journal of Crohn's & Colitis, vol. 8, no. 12, pp. 1642–1652, 2014. View at Publisher · View at Google Scholar · View at Scopus